Other
Gross Assets/Liabilities
Pfizer Gross Assets/Liabilities decreased by 6.4% to $1.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.9%, from $1.31B to $1.37B. Over 5 years (FY 2020 to FY 2025), Gross Assets/Liabilities shows an upward trend with a 5.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
Significant growth in gross figures relative to net figures may indicate increased complexity and potential balance sheet expansion.
Detailed definition
This represents the total carrying value of assets or liabilities before any netting arrangements are applied. It provid...
Peer comparison
Used to compare the scale of operations and the impact of netting policies across different banks.
Metric ID:
gross_assets_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $959.00M | $823.00M | $881.00M | $930.00M | $1.29B | $1.78B | $1.89B | $1.49B | $1.61B | $1.47B | $1.42B | $1.15B | $1.23B | $1.51B | $1.37B | $1.31B | $1.91B | $1.58B | $1.46B | $1.37B |
| QoQ Change | — | -14.2% | +7.0% | +5.6% | +38.8% | +37.6% | +6.3% | -21.2% | +7.9% | -8.6% | -3.3% | -19.3% | +7.2% | +22.8% | -9.4% | -3.8% | +45.4% | -17.5% | -7.5% | -6.4% |
| YoY Change | — | — | — | — | +34.6% | +115.9% | +114.4% | +60.0% | +24.4% | -17.4% | -24.8% | -23.0% | -23.5% | +2.7% | -3.8% | +14.7% | +55.6% | +4.6% | +6.7% | +3.9% |
Range$823.00M – $1.91B
CAGR+7.7%
Avg YoY Growth+21.6%
Median YoY Growth+5.7%
Current Streak3 quarters decline
Gross Assets/Liabilities at Other Companies
Frequently Asked Questions
- What is Pfizer's gross assets/liabilities?
- Pfizer (PFE) reported gross assets/liabilities of $1.37B in Q1 2026.
- How has Pfizer's gross assets/liabilities changed year-over-year?
- Pfizer's gross assets/liabilities increased by 3.9% year-over-year, from $1.31B to $1.37B.
- What is the long-term trend for Pfizer's gross assets/liabilities?
- Over 5 years (2020 to 2025), Pfizer's gross assets/liabilities has grown at a 5.8% compound annual growth rate (CAGR), from $1.10B to $1.46B.
- What does gross assets/liabilities mean?
- The total value of assets or liabilities before any netting or offsets are applied.